Reckitt Benckiser has issued a voluntary recall for Mead Johnson Nutrition brand's baby formula powder. The U.S. Food and Drug Administration (US FDA) said that the health and nutrition firm decided to recall some batches of the said product due to possible bacterial contamination.
As per CNBC, the affected infant formula is being sold in the market as Nutramigen Powder. This infant formula is specially made for babies allergic to cow's milk. The recalled batches were produced in June and distributed to stores in the summer.
Recalled Batches of Nutramigen Powder
Reckitt Benckiser said that so far, it has not received any reports of illnesses or adverse effects related to the recalled Nutramigen Powder. However, the company is urging customers who have bought the milk formula to check the can to see if what they purchased is included in the batches that may have been contaminated.
The company said that the affected products have these batch numbers and their corresponding can sizes: ZL3FHG, 12.6 oz cans, ZL3FMH, 12.6 oz cans, ZL3FPE, 12.6 oz cans, ZL3FQD, 12.6 oz cans, ZL3FRW, 19.8 oz cans, and ZL3FXJ, 12.6 oz cans.
Adverse Effects of Bacterial Infection
Fox Business says the total number of the affected Nutramigen infant powder is about 675,030 cans. The FDA warned on Sunday, Dec. 31, that they may be contaminated with Cronobacter sakazakii.
The National Food Administration further said that the milk formula was made at a production facility in Michigan. The bacteria in the product potentially cause severe infections such as meningitis and sepsis. The FDA listed jaundice, irritability, temperature change, poor feeding, trouble breathing, and unusual movements as the common symptoms of the infection.
Meanwhile, the announcement stressed, "No other U.S. distributed Nutramigen batches or other Reckitt products are impacted."
Photo by: Reckltt Press Release


Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Alphabet Replaces Verizon in Dow Jones Industrial Average
US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 



